GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OTCPK:OSSFF) » Definitions » Intrinsic Value: Projected FCF

OSSFF (Embla Medical hf) Intrinsic Value: Projected FCF : $2.60 (As of Jun. 23, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Embla Medical hf Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2025-06-23), Embla Medical hf's Intrinsic Value: Projected FCF is $2.60. The stock price of Embla Medical hf is $4.15. Therefore, Embla Medical hf's Price-to-Intrinsic-Value-Projected-FCF of today is 1.6.

The historical rank and industry rank for Embla Medical hf's Intrinsic Value: Projected FCF or its related term are showing as below:

OSSFF' s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 1.35   Med: 1.86   Max: 3.29
Current: 1.6

During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Embla Medical hf was 3.29. The lowest was 1.35. And the median was 1.86.

OSSFF's Price-to-Projected-FCF is ranked worse than
51.56% of 384 companies
in the Medical Devices & Instruments industry
Industry Median: 1.525 vs OSSFF: 1.60

Embla Medical hf Intrinsic Value: Projected FCF Historical Data

The historical data trend for Embla Medical hf's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embla Medical hf Intrinsic Value: Projected FCF Chart

Embla Medical hf Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.57 2.25 2.28 2.90 2.92

Embla Medical hf Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.39 2.76 2.87 2.92 3.08

Competitive Comparison of Embla Medical hf's Intrinsic Value: Projected FCF

For the Medical Devices subindustry, Embla Medical hf's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Embla Medical hf's Price-to-Projected-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Embla Medical hf's Price-to-Projected-FCF falls into.


;
;

Embla Medical hf Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Embla Medical hf's Free Cash Flow(6 year avg) = $60.30.

Embla Medical hf's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Mar25)*0.8)/Shares Outstanding (Diluted Average)
=(10.623553629896*60.29504+798.076*0.8)/434.250
=2.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Embla Medical hf  (OTCPK:OSSFF) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Embla Medical hf's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=4.15/2.9453273254041
=1.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Embla Medical hf Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Embla Medical hf's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Embla Medical hf Business Description

Traded in Other Exchanges
Address
Grjothals 5, Reykjavik, ISL
Embla Medical hf is is an Iceland-based company that operates within the field of medical equipment and supplies sector. The Company is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. Embla Medical operates within three business segments of the non-invasive orthopedics market; Prosthetics and Neuro Orthotics; Bracing and Supports; and Patient Care. Key revenue is generated from Prosthetics and Neuro Orthotics; segment.

Embla Medical hf Headlines

From GuruFocus

Q1 2020 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2023 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2024 Embla Medical hf Earnings Call Transcript

By GuruFocus News 10-30-2024

Q2 2020 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2024 Embla Medical hf Earnings Call Transcript

By GuruFocus News 02-06-2025

Q3 2022 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024

Embla Medical hf: Interim Report Q3 2024

By PRNewswire 10-22-2024

Q3 2020 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2020 Ossur hf Earnings Call Transcript

By GuruFocus Research 02-14-2024